05 Compliance

The regulatory file for casein phosphopeptides

Technical document 05 · Reviewed 2026-11-19 · Casein Phosphopeptides

On this page
  1. What the file has to answer
  2. European Union
  3. United States
  4. Contaminants and limits
  5. Claims and the label
  6. The document pack
  7. Checklist before the first order

Casein phosphopeptides (CPP) are a milk-derived peptide, and the regulatory question is destination-specific: whether the exact CPP has a route in the market, how the milk allergen is declared, which contaminant limits apply to the product as sold, and whether the label carries any claim. The supplier keeps the specification, the allergen statement and the lot file; the buyer’s regulatory team confirms the route. This page lists the framework and the documents.

In one line

The regulatory file follows the destination: CPP is a milk-derived peptide, and the buyer’s regulatory team confirms the route, the allergen declaration and the claims before the label is set.

What the file has to answer

Four questions. What is the material, and which specification version is being bought? Which lot is being released, and what does its certificate report? Which route and limits apply in the destination? And what changes if the source, the process or the pack changes?

The COA answers the lot question, the technical data sheet answers the specification question, and the safety data sheet answers the handling question. None of them answers the route question on its own. The file should also carry the allergen statement, the origin record and any customer-specific declaration, with version numbers rather than a folder of undated PDFs.

European Union

The EU file starts with the general food law, Regulation (EC) No 178/2002, and the food information rules in Regulation (EU) No 1169/2011. Milk and products thereof are on the Annex II allergen list, so a CPP-containing product has to declare milk in the ingredient list and emphasise it. A low-lactose or highly hydrolysed ingredient does not remove the declaration unless the destination provides a specific exemption.

Whether the exact CPP is inside the novel-food framework, Regulation (EU) 2015/2283, depends on its history of use and its production process. A peptide fraction made by enzymatic hydrolysis is not automatically outside that regulation because the parent casein has a long history of use. The buyer’s regulatory team checks the current novel-food catalogue and the member state position before the launch.

Food supplements fall under Directive 2002/46/EC, contaminants under Regulation (EU) 2023/915, and claims under Regulation (EC) No 1924/2006, as of this review. Great Britain applies the retained GB texts and Northern Ireland applies the EU framework; the two are checked separately.

United States

In the US the route depends on the basis the supplier relies on: a dietary ingredient with a documented history of use, a GRAS basis, or a new dietary ingredient notification under 21 U.S.C. 350b. The supplier names the basis and the supporting document; the buyer confirms that it covers the finished product and the intended use.

The facility meets 21 CFR 111 for a supplement or 21 CFR 117 for a conventional food, and the label follows 21 CFR 101. Milk is a major food allergen under FALCPA, so the declaration follows the protein, not the lactose figure. California Proposition 65 may also apply to lead, and its threshold is daily-intake based, so a lot inside a specification can still trigger a warning at a high daily portion.

Contaminants and limits

Contaminant limits · CPP sold as a food supplement, by market
ElementEU food supplement limitUS federal limitWhat the file shows
Lead3.0 mg/kgNo federal limit specific to supplements; state rules may applyLot result, method and finished-product calculation
Cadmium1.0 mg/kg; category exceptions applyNo federal limit specific to supplementsLot result and the category check
Mercury0.10 mg/kgNo federal limit specific to supplementsLot result and method
ArsenicNot harmonised; member state rules may applyNo federal limit specific to supplementsThe agreed limit and the method

The EU figures come from Regulation (EU) 2023/915 and apply to the product as sold. An ingredient sold to a food manufacturer is assessed against the limit for the food category it enters, which can be tighter or looser. Arsenic is not harmonised at EU level, so the specification has to state the limit it is tested against. The catalog limits on this site sit inside those frameworks, with arsenic as a customer limit.

Claims and the label

No disease-related claim is permitted in the EU, the US or the UK. As of this review, we have not identified an authorised health claim for casein phosphopeptides as such; the authorised calcium claims attach to calcium, not to the peptide, and they carry conditions of use. The buyer’s reviewer checks the current register. The source-of-calcium condition is at least 15% of the nutrient reference value in the daily dose, which is 120 mg against the 800 mg reference value. At 2.0–4.0% calcium, a 500 mg capsule delivers 10–20 mg calcium, a small fraction of that figure.

The protein side is a different calculation. A 500 mg capsule at 80% protein carries about 0.4 g protein, and the claim calculation belongs to the finished product, not to the ingredient name. A claim about calcium absorption is a health claim and needs its own authorisation or notification in the destination; it cannot be carried on the ingredient page or the label without that route.

The label names the material as casein phosphopeptides and declares milk. “Dairy-free” and “lactose-free” are separate claims with their own basis, and neither is available for a product that contains a milk-derived peptide. The brand’s reviewer confirms the wording for the market.

The document pack

  • Specification with the revision, the peptide method and the protein factor and basis.
  • Batch COA with results and methods, not only a conformity statement.
  • Allergen statement naming milk, repeated on the COA.
  • Origin, non-GMO and, where required, halal or kosher statements.
  • SDS and the site’s GMP, HACCP or ISO certificates.
  • Melamine and cyanuric acid statement where the buyer’s market asks for it.
  • Third-party report where the customer requires one.

Checklist before the first order

  1. Is the exact CPP and its route confirmed for the destination?
  2. Is milk declared on the label and on the allergen statement?
  3. Do the contaminant results meet the limit for the product as sold?
  4. Is any claim based on the calcium or protein actually delivered, with the arithmetic shown?
  5. Does the file carry the COA with methods, the specification revision and the site certificates?
  6. Has the current text been checked this year, not at the last launch?

The catalog specification sits on the casein phosphopeptide product page; the certificate is explained on the COA page; the analytical evidence is on the identity page; the EU and US summaries give the framework; the Annex II entry covers the allergen; the quality page describes the release file.

Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.

Request a quotation